Evidence map›Paper›PMID 41782801›Full record

ArticleBioinformatics and biology insights2026

Leveraging Artificial Intelligence to Advance Bioinformatics in Africa: Opportunities, Challenges, and Ethical Considerations in Combating Antimicrobial Resistance.

Beatus Lyimo

Abstract read
In one paragraph

Article in Bioinformatics and biology insights, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Beatus LyimoSchool of Life Science and Bio-Engineering (LiSBE), Nelson Mandela African Institution of Science and Technology (NM-AIST), Arusha, Tanzania.ORCID https://orcid.org/0000-0002-6743-4546

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Africa continues to bear a disproportionate burden of infectious diseases, particularly antimicrobial-resistant (AMR) infections, which significantly affect public health and socio-economic development. Addressing these complex health threats requires innovative approaches to data analysis, pathogen surveillance, and intervention design. The emergence of advanced computational tools especially artificial intelligence (AI) is expected to reduce turnaround times for AMR prediction from days to hours by leveraging whole-genome sequencing (WGS)-based models. This article explores the synergistic integration of AI and bioinformatics, focusing on their application in combating AMR in Africa. It details how AI techniques, particularly machine learning (ML) and deep learning (DL) algorithms, can enhance genomic research by automating the analysis of large-scale sequence datasets, predicting resistance patterns, and modeling infections transmission dynamics. In regions with limited laboratory capacity, AI models can detect resistance genes rapidly and assist clinicians in selecting appropriate antibiotics, offering a faster and more scalable alternative to traditional diagnostics. Tools such as convolutional neural networks (CNNs) and support vector machines (SVMs) are examples of models capable of classifying pathogen strains based on genetic data. Furthermore, the article highlights the emerging role of large language models (LLMs) in supporting bioinformatics workflows. These tools aid researchers by generating analysis scripts, interpreting complex outputs, troubleshooting code errors, summarizing literature, and preparing manuscripts or grant proposals particularly benefiting early-career scientists who may lack access to advanced training or mentorship. Despite notable progress, significant challenges remain, including limited infrastructure, barriers to data sharing, and the urgent need for ethical guidelines and policies to govern AI integration. Ultimately, this article underscores the transformative potential of AI in advancing bioinformatics across Africa and advocates for sustained investment in infrastructure, capacity-building, and responsible policy frameworks to harness AI for improved health research and disease control outcomes. We propose 3 priority actions: building African AMR genomic datasets, investing in AI-ready infrastructure, and developing responsible data-governance frameworks.

Indexed as

AI-enabled diagnosticsAMRArtificial intelligencebioinformaticsgenomic AMR predictiongenomic surveillance

Identifiers

PMID41782801
PMCPMC12953961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.